Frontlight ResearchEarly access
Head and neck cancer trials in United States
391 trials · From ClinicalTrials.gov, checked 18 November 2026. Ask the study team whether a trial fits you.
- Phase 1Taking peopleDecitabine in Combination With Standard of Care Therapy for the Treatment of Surgically Resectable HPV-Negative Head and Neck Cancer
- Where
- Jacksonville
- Age
- 18 years and over
- People
- 32
- Run by
- Mayo Clinic
See details and how to joinNCT06997094 - No phaseNot yet taking people in United StatesPeer Support Program for Improving Quality of Life Among Head and Neck Patients, Connecting Through Cancer Trial
- Where
- Portland
- Age
- 18 years to 89 years
- People
- 56
- Run by
- OHSU Knight Cancer Institute
See details and how to joinNCT07664241 - Phase 3Taking peopleSPECT-CT Guided ELEctive Contralateral Neck Treatment for Patients With Lateralized Oropharyngeal Cancer
- Where
- Ann Arbor, Atlanta, Berlin Corners, Brighton, Burlington, Chapel Hill, Chicago, Cleveland, Columbia, Conroe, Coral Gables, Corona, Detroit, Duarte, Houston, Irvine, Jacksonville, League City, Louisville, Miami, Portland, Sugar Land, Tampa, Warrenville
- Age
- 18 years and over
- People
- 510 worldwide
- Run by
- Canadian Cancer Trials Group
See details and how to joinNCT05451004 - Phase 2Taking peopleRepurposing Riluzole for Cancer-Related Cognitive Impairment: A Pilot Trial
- Where
- Orange
- Age
- 18 years and over
- People
- 75
- Run by
- University of California, Irvine
See details and how to joinNCT06580002 - Phase 2Taking peopleEvaluating a Decreased Dose of Radiation Therapy to the Elective Neck for the Treatment of HPV-Related Oropharyngeal Cancer, ENLIGHT Trial
- Where
- Chicago, Warrenville
- Age
- 18 years and over
- People
- 100
- Run by
- Northwestern University
See details and how to joinNCT07178301 - No phaseTaking peopleLocally ablatiVe therApy in oLigO-pRogressive sOlid tUmorS (VALOROUS)
- Where
- Sacramento
- Age
- 18 years and over
- People
- 250
- Run by
- University of California, Davis
See details and how to joinNCT06103669 - Phase 1/2Taking peopleFirst-in-Human Study of Tersolisib (STX-478) as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors
- Where
- Atlanta, Aurora, Boston, Cleveland, Columbus, Dallas, Detroit, Fairfax, Germantown, Grand Rapids, Houston, Iowa City, Kansas City, Lake Mary, Los Angeles, Nashville, New Haven, New Orleans, New York, Portland, San Antonio, San Francisco, St Louis, Tampa, West Valley City
- Age
- 18 years and over
- People
- 880 worldwide
- Run by
- Eli Lilly and Company
See details and how to joinNCT05768139 · EU 2023-504807-94-00 - Phase 2Taking peopleIntraoperative Molecular Imaging Using ICG for Head and Neck Tumors
- Where
- Charleston
- Age
- 18 years and over
- People
- 30
- Run by
- Medical University of South Carolina
See details and how to joinNCT07149207 - Phase 1Taking peopleA Study of Sigvotatug Vedotin in Advanced Solid Tumors
- Where
- Anaheim, Anchorage, Babylon, Bonney Lake, Boston, Brooklyn, Calumet City, Chicago, Cleveland, Coon Rapids, Crown Point, Edmonds, Fairfax, Fairway, Fayetteville, Federal Way, Flossmoor, Fort Myers, Fort Wayne, Fullerton, Gig Harbor, Harvey, Hollywood, Houston, Indianapolis, Irving, Kansas City, Las Vegas, Los Alamitos, Los Angeles, Minneapolis, Nashville, New Hyde Park, New Lenox, Newton, New York, Oklahoma City, Olympia, Orlando, Orland Park, Overland Park, Patchogue, Pearland, Pembroke Pines, Port Jefferson Station, Portland, Puyallup, Riverhead, Rogers, Saint Paul, San Antonio, Santa Monica, Seattle, Shirley, Sioux Falls, Springdale, Springfield, Tacoma, The Bronx, Tinley Park, Torrance, Tyler, Webster, Westwood
- Age
- 18 years and over
- People
- 1,006 worldwide
- Run by
- Seagen, a wholly owned subsidiary of Pfizer
See details and how to joinNCT04389632 · EU 2023-508469-34-00 - No phaseTaking peopleImplementing the NYU Electronic Patient Visit Assessment (ePVA) for Head and Neck Cancer In Rural and Urban Populations
- Where
- Houston, Kansas City, New York, Philadelphia
- Age
- 18 years and over
- People
- 270
- Run by
- The University of Texas Health Science Center, Houston
See details and how to joinNCT06030011 - No phaseTaking peopleIdentification of Secreted Markers for Tumor Hypoxia in Patients With Head and Neck or Lung Cancers
- Where
- Stanford
- Age
- 18 years and over
- People
- 200
- Run by
- Stanford University
See details and how to joinNCT00568490 - Phase 1/2Taking peoplePhase I/ II Trial Combining PD-1 Inhibition and Neoadjuvant Proton or Photon Radiation Therapy in Recurrent Head and Neck Squamous Cell Carcinoma
- Where
- Cincinnati
- Age
- 18 years and over
- People
- 40
- Run by
- University of Cincinnati
See details and how to joinNCT07213934 - No phaseTaking peopleClonal Hematopoiesis Chemotherapy and Radiation Effects Study
- Where
- Boston
- Age
- 18 years and over
- People
- 5,000
- Run by
- Dana-Farber Cancer Institute
See details and how to joinNCT07675967 - No phaseTaking peopleIntegrated Cancer Repository for Cancer Research
- Where
- Aitkin, Alliance, Aurora, Bozeman, Brainerd, Canton, Council Bluffs, Daytona Beach, DeLand, Duluth, Fargo, Fayetteville, Fergus Falls, Fort Wayne, Glens Falls, Green Bay, Greenwood Village, Hastings, Holyoke, Kansas City, Liberty, Manchester, Minot, Norfolk, North Kansas City, North Platte, Omaha, Orange City, Overland Park, Palm Coast, Randallstown, Saint Joseph, Tallahassee, Utica, Waterloo, Westminster, Yorkville
- Age
- 19 years to 110 years
- People
- 999,999
- Run by
- University of Nebraska
See details and how to joinNCT02012699 - No phaseTaking peopleCognitive Outcomes After Brain Substructure-informed Radiation Planning in Pediatric Patients
- Where
- Baltimore, Washington D.C.
- Age
- 1 year to 26 years
- People
- 338
- Run by
- Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
See details and how to joinNCT05658731 - No phaseTaking peoplePredicting Response to Immunotherapy From Analysis of Live Tumor Biopsies (ELEPHAS-05)
- Where
- Forth Worth, Fort Smith, Frederick, Oklahoma City, Springfield, St Louis, Temple
- Age
- 18 years and over
- People
- 2,000
- Run by
- Elephas
See details and how to joinNCT07327489 - Phase 1/2Taking peopleHigh Dose Steroid Therapy (Prednisone or Methylprednisolone) for the Improvement of Symptoms of Late Radiation-Associated Lower Cranial Neuropathy in Oropharyngeal Cancer Survivors
- Where
- Houston
- Age
- 18 years and over
- People
- 35
- Run by
- M.D. Anderson Cancer Center
See details and how to joinNCT04151082 - Phase 2Taking peopleIvonescimab Before Surgery for the Treatment of Resectable Stage II-IV Head and Neck Cancer
- Where
- Ann Arbor
- Age
- 18 years and over
- People
- 28
- Run by
- University of Michigan Rogel Cancer Center
See details and how to joinNCT07094685 - Phase 2Taking peopleAnti-PD-1 mAb Plus Metabolic Modulator in Solid Tumor Malignancies
- Where
- Pittsburgh
- Age
- 18 years and over
- People
- 72
- Run by
- Dan Zandberg
See details and how to joinNCT04114136 - Phase 1Taking peopleStudy to Assess Adverse Events and Pharmacokinetics in Adult Participants With Non-Small Cell Lung Cancer, Head and Neck Squamous Cell Carcinoma and Other Solid Tumors, Receiving Intravenous Infusion of Azirkitug Alone or in Combination(s) With Budigalimab, Bevacizumab, or Telisotuzumab Adizutecan
- Where
- Austin, Chicago, Duarte, Durham, Fairfax, Fort Wayne, Grand Rapids, Houston, Huntersville, Indianapolis, Irvine, Irving, Los Angeles, Louisville, Minneapolis, Omaha, San Antonio, West Valley City
- Age
- 18 years and over
- People
- 694 worldwide
- Run by
- AbbVie
See details and how to joinNCT05005403 - Phase 2Taking peoplePreoperative Pembrolizumab and Chemotherapy in Resectable, Recurrent HNSCC
- Where
- Boston
- Age
- 18 years and over
- People
- 28
- Run by
- Dana-Farber Cancer Institute
See details and how to joinNCT05726370 - No phaseTaking peoplePhotobiomodulation in Head and Neck Cancer-Related Chronic Lymphedema
- Where
- Nashville, Philadelphia
- Age
- 18 years and over
- People
- 150
- Run by
- Abramson Cancer Center at Penn Medicine
See details and how to joinNCT06837480 - Phase 1/2Taking peoplePh. I/II Sodium Thiosulfate for OtoProtection During Cisplatin (STOP-CIS)
- Where
- Tucson
- Age
- 18 years and over
- People
- 25
- Run by
- University of Arizona
See details and how to joinNCT07407582 - No phaseNot yet taking people in United StatesREVIVE Prospective Registry Cohort Study
- Where
- Sacramento, San Francisco
- Age
- 18 years and over
- People
- 31
- Run by
- University of California, Davis
See details and how to joinNCT07429890 - Phase 1Taking peopleMEM-288 Oncolytic Virus Alone and in Combination With Standard of Care Therapy in Advanced Solid Tumors
- Where
- Durham, Tampa
- Age
- 18 years and over
- People
- 40
- Run by
- Memgen, Inc.
See details and how to joinNCT05076760